 Laurel Lenz
Concepts (290)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Listeria monocytogenes | 28 | 2021 | 111 | 7.430 |
Why?
| | Listeriosis | 19 | 2021 | 61 | 5.340 |
Why?
| | Killer Cells, Natural | 12 | 2021 | 380 | 3.260 |
Why?
| | Interferon-gamma | 12 | 2019 | 719 | 2.500 |
Why?
| | Interleukin-10 | 5 | 2021 | 299 | 2.330 |
Why?
| | Receptors, Interferon | 8 | 2019 | 47 | 2.090 |
Why?
| | Myeloid Cells | 5 | 2020 | 126 | 2.040 |
Why?
| | Interferon Type I | 7 | 2019 | 128 | 1.670 |
Why?
| | Macrophages | 12 | 2020 | 1261 | 1.620 |
Why?
| | Interleukin-18 | 4 | 2018 | 219 | 1.310 |
Why?
| | Streptococcus pneumoniae | 2 | 2020 | 133 | 1.270 |
Why?
| | Dendritic Cells | 9 | 2018 | 435 | 1.170 |
Why?
| | Immunity, Innate | 12 | 2021 | 720 | 1.140 |
Why?
| | Bacterial Infections | 4 | 2018 | 218 | 1.050 |
Why?
| | Interferon-beta | 3 | 2018 | 79 | 1.030 |
Why?
| | Host-Pathogen Interactions | 3 | 2020 | 295 | 0.960 |
Why?
| | Mice, Inbred C57BL | 20 | 2021 | 4692 | 0.930 |
Why?
| | Bacterial Proteins | 7 | 2018 | 736 | 0.910 |
Why?
| | Animals | 51 | 2022 | 31698 | 0.900 |
Why?
| | Mice | 40 | 2022 | 14863 | 0.880 |
Why?
| | Interferon-alpha | 2 | 2018 | 186 | 0.880 |
Why?
| | Repressor Proteins | 2 | 2018 | 366 | 0.840 |
Why?
| | Mice, Knockout | 15 | 2021 | 2568 | 0.830 |
Why?
| | STAT3 Transcription Factor | 3 | 2022 | 173 | 0.810 |
Why?
| | Interleukin-15 | 2 | 2019 | 74 | 0.740 |
Why?
| | Casein Kinase II | 1 | 2020 | 21 | 0.730 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2020 | 38 | 0.670 |
Why?
| | Orthomyxoviridae Infections | 1 | 2020 | 54 | 0.670 |
Why?
| | Bacteria | 3 | 2018 | 725 | 0.660 |
Why?
| | N-Acetylmuramoyl-L-alanine Amidase | 3 | 2009 | 8 | 0.660 |
Why?
| | Influenza A virus | 1 | 2020 | 90 | 0.660 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2018 | 144 | 0.650 |
Why?
| | Lymphocyte Activation | 4 | 2016 | 1037 | 0.650 |
Why?
| | Pneumococcal Infections | 1 | 2020 | 91 | 0.640 |
Why?
| | Coinfection | 1 | 2020 | 120 | 0.630 |
Why?
| | Streptococcal Infections | 1 | 2020 | 131 | 0.620 |
Why?
| | Macrophage Activation | 4 | 2017 | 164 | 0.610 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 39 | 0.600 |
Why?
| | Disease Susceptibility | 4 | 2021 | 316 | 0.560 |
Why?
| | Leukocytes, Mononuclear | 1 | 2019 | 493 | 0.550 |
Why?
| | Pneumonia | 1 | 2021 | 567 | 0.510 |
Why?
| | Flow Cytometry | 4 | 2016 | 1083 | 0.510 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 338 | 0.480 |
Why?
| | Bacterial Vaccines | 2 | 2020 | 61 | 0.470 |
Why?
| | T-Lymphocytes, Cytotoxic | 6 | 2007 | 154 | 0.460 |
Why?
| | Influenza, Human | 1 | 2020 | 546 | 0.460 |
Why?
| | Lung Diseases | 1 | 2020 | 701 | 0.450 |
Why?
| | Early Growth Response Protein 3 | 1 | 2013 | 1 | 0.440 |
Why?
| | Interferon Regulatory Factor-3 | 3 | 2011 | 17 | 0.430 |
Why?
| | Antigens, Bacterial | 4 | 1998 | 112 | 0.430 |
Why?
| | Gene Silencing | 1 | 2013 | 171 | 0.410 |
Why?
| | Toll-Like Receptors | 3 | 2012 | 167 | 0.410 |
Why?
| | H-2 Antigens | 3 | 1997 | 110 | 0.400 |
Why?
| | Anthrax | 1 | 2012 | 8 | 0.400 |
Why?
| | Gene Expression | 3 | 2019 | 1421 | 0.400 |
Why?
| | Bacillus anthracis | 1 | 2012 | 11 | 0.400 |
Why?
| | Lung | 3 | 2019 | 3559 | 0.400 |
Why?
| | Lymph Nodes | 2 | 2012 | 419 | 0.390 |
Why?
| | Cyclic GMP | 1 | 2011 | 80 | 0.380 |
Why?
| | Peptidoglycan | 2 | 2009 | 25 | 0.370 |
Why?
| | Inflammasomes | 1 | 2012 | 115 | 0.370 |
Why?
| | Membrane Proteins | 4 | 2021 | 1018 | 0.360 |
Why?
| | Cyclic AMP | 1 | 2011 | 227 | 0.360 |
Why?
| | Interleukin-1beta | 1 | 2012 | 370 | 0.350 |
Why?
| | Cells, Cultured | 6 | 2019 | 3885 | 0.350 |
Why?
| | Recombinant Proteins | 3 | 2011 | 1230 | 0.340 |
Why?
| | Down-Regulation | 5 | 2019 | 594 | 0.330 |
Why?
| | Antigens | 1 | 2011 | 318 | 0.330 |
Why?
| | Mice, Transgenic | 5 | 2021 | 1947 | 0.330 |
Why?
| | CD5 Antigens | 1 | 2009 | 8 | 0.320 |
Why?
| | Intubation, Intratracheal | 1 | 2011 | 216 | 0.320 |
Why?
| | Mice, Inbred BALB C | 8 | 2012 | 1143 | 0.310 |
Why?
| | Bone Marrow Cells | 3 | 2010 | 267 | 0.310 |
Why?
| | Lymphocytes | 2 | 2014 | 330 | 0.310 |
Why?
| | Cell Communication | 1 | 2010 | 279 | 0.310 |
Why?
| | Recombination, Genetic | 1 | 2008 | 176 | 0.290 |
Why?
| | Head and Neck Neoplasms | 2 | 2021 | 427 | 0.280 |
Why?
| | Genetic Vectors | 1 | 2008 | 289 | 0.280 |
Why?
| | Antigen Presentation | 3 | 1998 | 188 | 0.280 |
Why?
| | Lipopolysaccharides | 3 | 2021 | 821 | 0.280 |
Why?
| | Nitric Oxide | 1 | 2012 | 823 | 0.280 |
Why?
| | B-Lymphocytes | 1 | 2012 | 766 | 0.280 |
Why?
| | Host-Parasite Interactions | 1 | 2007 | 94 | 0.270 |
Why?
| | Adenosine Triphosphatases | 2 | 2007 | 153 | 0.270 |
Why?
| | Selection, Genetic | 1 | 2008 | 242 | 0.270 |
Why?
| | Communicable Diseases | 1 | 2007 | 129 | 0.260 |
Why?
| | Female | 16 | 2021 | 59493 | 0.250 |
Why?
| | Inflammation | 3 | 2020 | 2478 | 0.250 |
Why?
| | Epitopes | 2 | 1997 | 435 | 0.240 |
Why?
| | Cytotoxicity, Immunologic | 3 | 2003 | 195 | 0.220 |
Why?
| | Cytokines | 5 | 2020 | 1840 | 0.210 |
Why?
| | Coculture Techniques | 2 | 2016 | 201 | 0.210 |
Why?
| | Cell Line | 5 | 2012 | 2636 | 0.210 |
Why?
| | Disease Models, Animal | 3 | 2020 | 3532 | 0.210 |
Why?
| | Membrane Transport Proteins | 1 | 2003 | 138 | 0.200 |
Why?
| | Escherichia coli Proteins | 1 | 2003 | 162 | 0.200 |
Why?
| | Radioimmunotherapy | 1 | 2021 | 11 | 0.190 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 797 | 0.190 |
Why?
| | Virulence | 3 | 2008 | 227 | 0.190 |
Why?
| | Male | 10 | 2021 | 55583 | 0.190 |
Why?
| | Ligands | 4 | 2019 | 561 | 0.190 |
Why?
| | Humans | 19 | 2022 | 114662 | 0.190 |
Why?
| | Mouth Diseases | 1 | 2021 | 40 | 0.180 |
Why?
| | Transcription, Genetic | 2 | 2019 | 1313 | 0.180 |
Why?
| | Vaccinia | 1 | 2000 | 18 | 0.180 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2000 | 12 | 0.180 |
Why?
| | Antigen-Presenting Cells | 1 | 2000 | 150 | 0.170 |
Why?
| | Legionnaires' Disease | 1 | 2019 | 4 | 0.170 |
Why?
| | Legionella pneumophila | 1 | 2019 | 3 | 0.170 |
Why?
| | Signal Transduction | 6 | 2019 | 4512 | 0.170 |
Why?
| | Malaria, Cerebral | 1 | 2019 | 3 | 0.170 |
Why?
| | Bites and Stings | 1 | 2020 | 30 | 0.170 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2022 | 211 | 0.160 |
Why?
| | CD4 Antigens | 1 | 2019 | 123 | 0.160 |
Why?
| | STAT4 Transcription Factor | 1 | 2018 | 4 | 0.150 |
Why?
| | Enhancer Elements, Genetic | 1 | 2019 | 151 | 0.150 |
Why?
| | Solubility | 1 | 2018 | 223 | 0.150 |
Why?
| | Disease Progression | 2 | 2022 | 2380 | 0.150 |
Why?
| | Interleukin-2 | 1 | 2018 | 413 | 0.140 |
Why?
| | Monocytes | 1 | 2019 | 502 | 0.140 |
Why?
| | Macrophages, Alveolar | 1 | 2019 | 347 | 0.140 |
Why?
| | Survival Analysis | 1 | 2019 | 1211 | 0.130 |
Why?
| | Amino Acid Sequence | 5 | 2009 | 1982 | 0.130 |
Why?
| | Chromatin | 1 | 2019 | 428 | 0.130 |
Why?
| | NF-kappa B | 1 | 2019 | 641 | 0.130 |
Why?
| | Adoptive Transfer | 1 | 2016 | 195 | 0.130 |
Why?
| | Adenocarcinoma | 1 | 2022 | 795 | 0.130 |
Why?
| | Phosphorylation | 2 | 2010 | 1569 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 245 | 0.120 |
Why?
| | Pancreatic Neoplasms | 1 | 2022 | 731 | 0.120 |
Why?
| | Genotype | 1 | 2020 | 1760 | 0.120 |
Why?
| | Breeding | 1 | 2014 | 55 | 0.120 |
Why?
| | Housing, Animal | 1 | 2014 | 42 | 0.120 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 82 | 0.110 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2013 | 128 | 0.110 |
Why?
| | T-Lymphocyte Subsets | 2 | 2007 | 383 | 0.110 |
Why?
| | Reactive Oxygen Species | 2 | 2012 | 531 | 0.100 |
Why?
| | Interleukin-12 | 3 | 2011 | 110 | 0.100 |
Why?
| | Caspases, Initiator | 1 | 2012 | 18 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 313 | 0.100 |
Why?
| | Spores, Bacterial | 1 | 2012 | 19 | 0.100 |
Why?
| | Receptors, CCR7 | 1 | 2012 | 24 | 0.100 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2010 | 90 | 0.100 |
Why?
| | Gastrointestinal Microbiome | 1 | 2018 | 501 | 0.100 |
Why?
| | Phagosomes | 1 | 2012 | 38 | 0.100 |
Why?
| | Immunotherapy | 1 | 2016 | 474 | 0.100 |
Why?
| | Caspase 1 | 1 | 2012 | 140 | 0.100 |
Why?
| | Lymphocyte Depletion | 1 | 2012 | 116 | 0.100 |
Why?
| | Francisella tularensis | 1 | 2011 | 19 | 0.100 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2012 | 157 | 0.100 |
Why?
| | Immunologic Factors | 1 | 2013 | 220 | 0.100 |
Why?
| | Receptors, Complement | 1 | 2012 | 111 | 0.100 |
Why?
| | Instillation, Drug | 1 | 2011 | 9 | 0.090 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2012 | 107 | 0.090 |
Why?
| | Caspases | 1 | 2012 | 245 | 0.090 |
Why?
| | Vesiculovirus | 1 | 2011 | 9 | 0.090 |
Why?
| | Adaptive Immunity | 1 | 2012 | 155 | 0.090 |
Why?
| | Cell Death | 1 | 2012 | 322 | 0.090 |
Why?
| | Phagocytes | 1 | 2011 | 90 | 0.090 |
Why?
| | Immunoglobulin M | 1 | 2012 | 246 | 0.090 |
Why?
| | Blotting, Western | 1 | 2013 | 1147 | 0.090 |
Why?
| | TRPM Cation Channels | 1 | 2011 | 67 | 0.090 |
Why?
| | Immunologic Memory | 2 | 2007 | 313 | 0.090 |
Why?
| | Melanoma, Experimental | 1 | 2011 | 89 | 0.090 |
Why?
| | STAT1 Transcription Factor | 1 | 2010 | 64 | 0.090 |
Why?
| | Infant | 2 | 2020 | 7961 | 0.090 |
Why?
| | Histocompatibility Antigens Class I | 2 | 2003 | 172 | 0.090 |
Why?
| | Toll-Like Receptor 2 | 2 | 2007 | 110 | 0.080 |
Why?
| | Spleen | 2 | 2008 | 487 | 0.080 |
Why?
| | Receptors, Cell Surface | 2 | 2009 | 355 | 0.080 |
Why?
| | CD8-Positive T-Lymphocytes | 4 | 2008 | 687 | 0.080 |
Why?
| | Gene Deletion | 2 | 2008 | 356 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 923 | 0.080 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2022 | 339 | 0.080 |
Why?
| | Immunotherapy, Adoptive | 1 | 2011 | 184 | 0.080 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2013 | 333 | 0.080 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2010 | 352 | 0.080 |
Why?
| | Tumor Microenvironment | 2 | 2021 | 430 | 0.080 |
Why?
| | Alanine Racemase | 1 | 2008 | 2 | 0.080 |
Why?
| | Glutamate-Ammonia Ligase | 1 | 2008 | 5 | 0.080 |
Why?
| | Genetic Complementation Test | 1 | 2008 | 62 | 0.080 |
Why?
| | Liver | 3 | 2018 | 1637 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2012 | 695 | 0.080 |
Why?
| | AIDS Vaccines | 1 | 2008 | 41 | 0.080 |
Why?
| | Genes, Bacterial | 1 | 2008 | 157 | 0.070 |
Why?
| | Vaccines, Attenuated | 1 | 2008 | 112 | 0.070 |
Why?
| | Group IV Phospholipases A2 | 1 | 2007 | 45 | 0.070 |
Why?
| | Hemolysin Proteins | 1 | 2007 | 31 | 0.070 |
Why?
| | Macrophages, Peritoneal | 1 | 2007 | 93 | 0.070 |
Why?
| | Plasmids | 1 | 2008 | 343 | 0.070 |
Why?
| | Bacterial Toxins | 1 | 2007 | 103 | 0.070 |
Why?
| | Heat-Shock Proteins | 1 | 2007 | 113 | 0.070 |
Why?
| | Bystander Effect | 1 | 2007 | 15 | 0.070 |
Why?
| | Biological Transport | 1 | 2007 | 373 | 0.070 |
Why?
| | Fungi | 1 | 2007 | 124 | 0.070 |
Why?
| | Molecular Sequence Data | 4 | 2004 | 2785 | 0.070 |
Why?
| | Virulence Factors | 1 | 2007 | 139 | 0.070 |
Why?
| | Protein Structure, Tertiary | 1 | 2009 | 796 | 0.070 |
Why?
| | Obesity | 1 | 2018 | 2508 | 0.070 |
Why?
| | Autoantibodies | 1 | 2013 | 1346 | 0.070 |
Why?
| | Antibodies | 1 | 2007 | 371 | 0.060 |
Why?
| | Alleles | 2 | 2020 | 789 | 0.060 |
Why?
| | Antigens, CD1 | 1 | 2005 | 57 | 0.060 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2007 | 285 | 0.060 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2007 | 959 | 0.060 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2004 | 140 | 0.060 |
Why?
| | Aged | 2 | 2020 | 19069 | 0.060 |
Why?
| | Gene Expression Profiling | 1 | 2010 | 1518 | 0.060 |
Why?
| | Autolysis | 1 | 2003 | 3 | 0.060 |
Why?
| | SEC Translocation Channels | 1 | 2003 | 10 | 0.060 |
Why?
| | Interleukin-6 | 1 | 2007 | 676 | 0.050 |
Why?
| | Mutation | 3 | 2010 | 3345 | 0.050 |
Why?
| | Neoplasms | 1 | 2016 | 2097 | 0.050 |
Why?
| | T-Lymphocytes | 2 | 2007 | 1737 | 0.050 |
Why?
| | Cell Movement | 1 | 2005 | 868 | 0.050 |
Why?
| | Nucleoproteins | 1 | 2000 | 27 | 0.050 |
Why?
| | Vaccinia virus | 1 | 2000 | 27 | 0.050 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2000 | 20 | 0.040 |
Why?
| | Chimera | 1 | 2000 | 59 | 0.040 |
Why?
| | Base Sequence | 3 | 2004 | 2114 | 0.040 |
Why?
| | Nucleotides, Cyclic | 1 | 2020 | 15 | 0.040 |
Why?
| | Gene Knock-In Techniques | 1 | 2020 | 46 | 0.040 |
Why?
| | Major Histocompatibility Complex | 1 | 2000 | 217 | 0.040 |
Why?
| | Germ-Free Life | 1 | 2018 | 28 | 0.040 |
Why?
| | Fatty Acids, Volatile | 1 | 2018 | 47 | 0.040 |
Why?
| | Diet, Western | 1 | 2018 | 66 | 0.040 |
Why?
| | Proteomics | 1 | 2003 | 836 | 0.040 |
Why?
| | Bile Acids and Salts | 1 | 2018 | 171 | 0.040 |
Why?
| | Dysbiosis | 1 | 2018 | 146 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2020 | 610 | 0.030 |
Why?
| | Transformation, Bacterial | 1 | 1996 | 5 | 0.030 |
Why?
| | Feces | 1 | 2018 | 373 | 0.030 |
Why?
| | Gene Library | 1 | 1996 | 114 | 0.030 |
Why?
| | Pregnancy | 2 | 2018 | 5518 | 0.030 |
Why?
| | Adiposity | 1 | 2018 | 457 | 0.030 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 532 | 0.030 |
Why?
| | Rituximab | 1 | 2013 | 150 | 0.030 |
Why?
| | Mothers | 1 | 2018 | 651 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 2014 | 243 | 0.030 |
Why?
| | Parrots | 1 | 1992 | 1 | 0.030 |
Why?
| | Polyomaviridae | 1 | 1992 | 1 | 0.030 |
Why?
| | Bird Diseases | 1 | 1992 | 8 | 0.030 |
Why?
| | Capsid | 1 | 1992 | 75 | 0.020 |
Why?
| | Papillomaviridae | 1 | 1992 | 101 | 0.020 |
Why?
| | Interleukin-12 Receptor beta 2 Subunit | 1 | 2011 | 2 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2007 | 1139 | 0.020 |
Why?
| | Body Weight | 1 | 2014 | 869 | 0.020 |
Why?
| | Disulfides | 1 | 2010 | 90 | 0.020 |
Why?
| | Dimerization | 1 | 2010 | 176 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2010 | 257 | 0.020 |
Why?
| | Adjuvants, Immunologic | 1 | 2011 | 206 | 0.020 |
Why?
| | Cancer Vaccines | 1 | 2011 | 137 | 0.020 |
Why?
| | Cysteine | 1 | 2010 | 171 | 0.020 |
Why?
| | Autoimmunity | 1 | 2014 | 813 | 0.020 |
Why?
| | Antibodies, Viral | 1 | 1992 | 520 | 0.020 |
Why?
| | Arachidonic Acids | 1 | 2007 | 56 | 0.020 |
Why?
| | Indomethacin | 1 | 2007 | 70 | 0.020 |
Why?
| | Mice, Inbred ICR | 1 | 2007 | 109 | 0.020 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2007 | 72 | 0.020 |
Why?
| | Cyclooxygenase 2 | 1 | 2007 | 164 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 157 | 0.020 |
Why?
| | Cytosol | 1 | 2007 | 208 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2007 | 276 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 1992 | 1262 | 0.020 |
Why?
| | Calcium Signaling | 1 | 2007 | 217 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2007 | 785 | 0.020 |
Why?
| | Neutrophils | 1 | 2011 | 1176 | 0.020 |
Why?
| | Antigens, CD1d | 1 | 2005 | 63 | 0.020 |
Why?
| | Muromegalovirus | 1 | 2004 | 13 | 0.020 |
Why?
| | Mycobacterium bovis | 1 | 2004 | 11 | 0.020 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 40 | 0.010 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 26 | 0.010 |
Why?
| | Interleukin-4 | 1 | 2005 | 206 | 0.010 |
Why?
| | Mast-Cell Sarcoma | 1 | 2003 | 4 | 0.010 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2004 | 171 | 0.010 |
Why?
| | Immunodominant Epitopes | 1 | 2003 | 25 | 0.010 |
Why?
| | Injections, Intravenous | 1 | 2003 | 198 | 0.010 |
Why?
| | Herpesviridae Infections | 1 | 2004 | 138 | 0.010 |
Why?
| | Clone Cells | 1 | 2003 | 247 | 0.010 |
Why?
| | Sequence Deletion | 1 | 2003 | 167 | 0.010 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2003 | 170 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 2004 | 430 | 0.010 |
Why?
| | Calcium | 1 | 2007 | 1108 | 0.010 |
Why?
| | Mice, Inbred DBA | 1 | 1998 | 173 | 0.010 |
Why?
| | Phenotype | 1 | 2005 | 2796 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2003 | 2710 | 0.010 |
Why?
| | Time Factors | 1 | 2004 | 6114 | 0.010 |
Why?
| | Peptides | 1 | 1998 | 848 | 0.010 |
Why?
| | Chick Embryo | 1 | 1992 | 122 | 0.010 |
Why?
| | Hybridomas | 1 | 1992 | 230 | 0.010 |
Why?
|
|
Lenz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|